Sensars
At a Glance
- Headquarters
- Unknown, US
About
Sensars is pioneering neuromodulation for diabetic neuropathy with SENSY, the first system to restore natural sensations to the feet, preventing complications like ulcers, amputations, falls, and addressing chronic neuropathic pain. The company has over 25 peer-reviewed publications, successful clinical studies, and FDA Breakthrough Device Designation.
Capabilities & Markets
Directory supply chains
Products
End markets served
Classification
NAICS Codes
Compliance & Registrations
Certifications
FDA Breakthrough Device Designation
compliance_program
Filterable Certifications & Statuses
FDABREAKTHROUGHDEVICEDESIGNATION